Literature DB >> 18682910

[Medicamentous thrombolysis in acute occlusions of extremity arteries].

T Kittner1, C Stelzner.   

Abstract

Local catheter-directed thrombolysis for thromboembolic extremity artery or bypass occlusions is a promising therapeutic option with comparatively low complication rates if the severity of the ischemia does not require an urgent surgical revascularization. This therapeutic decision has to be made by the vascular team under consideration of individual circumstances and contraindications. Apart from an adequate dosage, a strict intrathrombotic application of the fibrinolytic agent and careful clinical monitoring, including surveillance of the coagulation system is necessary. If needed, the thrombolysis therapy can be combined with interventional thrombaspiration and balloon dilatation or surgical correction of an underlying lesion.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18682910     DOI: 10.1007/s00117-008-1727-5

Source DB:  PubMed          Journal:  Radiologe        ISSN: 0033-832X            Impact factor:   0.635


  10 in total

1.  Thrombolysis in the management of lower limb peripheral arterial occlusion--a consensus document.

Authors: 
Journal:  J Vasc Interv Radiol       Date:  2003-09       Impact factor: 3.464

2.  Inter-Society Consensus for the Management of Peripheral Arterial Disease (TASC II).

Authors:  L Norgren; W R Hiatt; J A Dormandy; M R Nehler; K A Harris; F G R Fowkes; Kevin Bell; Joseph Caporusso; Isabelle Durand-Zaleski; Kimihiro Komori; Johannes Lammer; Christos Liapis; Salvatore Novo; Mahmood Razavi; Johns Robbs; Nicholaas Schaper; Hiroshi Shigematsu; Marc Sapoval; Christopher White; John White; Denis Clement; Mark Creager; Michael Jaff; Emile Mohler; Robert B Rutherford; Peter Sheehan; Henrik Sillesen; Kenneth Rosenfield
Journal:  Eur J Vasc Endovasc Surg       Date:  2006-11-29       Impact factor: 7.069

3.  Peripheral arteries: treatment with antibodies of platelet receptors and reteplase for thrombolysis--APART trial.

Authors:  Gunnar Tepe; Claudius Hopfenzitz; Klaus Dietz; Jakub Wiskirchen; Stephan Heller; Kenneth Ouriel; Gerhard Ziemer; Claus D Claussen; Stephan H Duda
Journal:  Radiology       Date:  2006-04-26       Impact factor: 11.105

4.  Peripheral arterial occlusions: a 6-year experience with local low-dose thrombolytic therapy.

Authors:  H Hess; A Mietaschk; R Brückl
Journal:  Radiology       Date:  1987-06       Impact factor: 11.105

Review 5.  Thrombolytic therapy with use of alteplase (rt-PA) in peripheral arterial occlusive disease: review of the clinical literature. The Advisory Panel.

Authors:  C P Semba; T P Murphy; C W Bakal; K A Calis; T A Matalon
Journal:  J Vasc Interv Radiol       Date:  2000-02       Impact factor: 3.464

6.  A comparison of recombinant urokinase with vascular surgery as initial treatment for acute arterial occlusion of the legs. Thrombolysis or Peripheral Arterial Surgery (TOPAS) Investigators.

Authors:  K Ouriel; F J Veith; A A Sasahara
Journal:  N Engl J Med       Date:  1998-04-16       Impact factor: 91.245

7.  Clinical and economic outcomes in thrombolytic treatment of peripheral arterial occlusive disease and deep venous thrombosis.

Authors:  Kenneth Ouriel; Alan F Kaul; Mandy C Leonard
Journal:  J Vasc Surg       Date:  2004-11       Impact factor: 4.268

Review 8.  Antithrombotic therapy in peripheral arterial occlusive disease: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy.

Authors:  G Patrick Clagett; Michael Sobel; Mark R Jackson; Gregory Y H Lip; Marco Tangelder; Raymond Verhaeghe
Journal:  Chest       Date:  2004-09       Impact factor: 9.410

9.  A comparison of thrombolytic therapy with operative revascularization in the initial treatment of acute peripheral arterial ischemia.

Authors:  K Ouriel; C K Shortell; J A DeWeese; R M Green; C W Francis; M V Azodo; O H Gutierrez; J V Manzione; C Cox; V J Marder
Journal:  J Vasc Surg       Date:  1994-06       Impact factor: 4.268

10.  Results of a prospective randomized trial evaluating surgery versus thrombolysis for ischemia of the lower extremity. The STILE trial.

Authors: 
Journal:  Ann Surg       Date:  1994-09       Impact factor: 12.969

  10 in total
  1 in total

1.  [Arterial occlusive disease. Catheter-directed thrombolytic therapy].

Authors:  C Stelzner; R Langhoff
Journal:  Internist (Berl)       Date:  2011-11       Impact factor: 0.743

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.